April 3, 2018 / 12:59 PM / 7 months ago

BRIEF-Eleven Biotherapeutics To Present Early Data From Bladder Cancer Trial In May

April 3 (Reuters) - Eleven Biotherapeutics Inc:

* PRELIMINARY DATA FROM PHASE 3 VISTA TRIAL IN BLADDER CANCER TO BE PRESENTED IN A PLENARY SESSION AT AMERICAN UROLOGICAL ASSOCIATION ANNUAL MEETING

* ELEVEN BIOTHERAPEUTICS-WITHIN SUBGROUP OF FIRST 75 EVALUABLE PATIENTS, PRELIM FINDINGS SHOW OVER 95 PCT EXPRESSED EPCAM ON SURFACE OF TUMOR CELLS​

* ELEVEN BIOTHERAPEUTICS INC - ‍VICINIUM HAS BEEN WELL-TOLERATED​​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below